Manténgase sano!

Daylight Saving Time Fails to Boost Daily Steps, Study Finds

TUESDAY, April 28, 2026 (HealthDay News) — Daylight saving time is thought to promote more outdoor activity by giving people an extra hour of sunshine in the evening prior to dusk.

But a new study says that’s just not so.

There’s no appreciable difference in people’s number of daily steps before and after...

Mail-In Colon Cancer Test Kits Offer Affordable Screening

TUESDAY, April 28, 2026 (HealthDay News) — Mail-in DNA tests for colon cancer can extend easy, affordable cancer screening to people who are struggling to get by, a new study says.

Patients at community health centers were more likely to participate in colon cancer screening if they were mailed a test kit that looks for abnormal...

Estrogen Patch Shortages Likely Driven By Empowered Women Seeking Relief, Expert Says

A new generation of empowered women could be driving the estrogen patch shortages now bedeviling the United States, the medical director of The Menopause Society told HealthDay TV.

“I think it's that women and clinicians and people in general are talking about menopause much more so now than in the past, which is a good thin...

First Gene Therapy for Genetic Hearing Loss Gains FDA Approval

In a historic leap for medical science, the U.S. Food and Drug Administration (FDA) has greenlit the first-ever gene therapy to treat a rare form of inherited deafness.

The treatment — called Otarmeni — offers a permanent solution for children born with a gene mutation that previously left them in total silence.

Otarmeni ...

Blood Glucose Monitors Improve Control Among Type 2 Diabetes Patients

Type 2 diabetes patients who wear a continuous glucose monitor have better blood sugar control than those who rely on traditional finger-prick testing, a new study says.

People equipped with a continuous glucose monitor (CGM) had greater reductions in hemoglobin A1c (HbA1c) levels, a marker of lower blood sugar, researchers reported April ...

Regaining Weight After Quitting Your GLP-1 Drug? A Simple Procedure Might Help, Study Says

Regaining the weight you’ve just lost is a major risk for anyone who decides to stop taking Ozempic or Zepbound.

But an experimental outpatient gut procedure might help people transition off their GLP-1 weight loss drug without packing on the pounds, according to new research scheduled for presentation at the Digestive Disease Week m...

Late-Night Noshing Could Contribute To Stress-Related Bathroom Problems

Late-night snacking could be worsening your stress-related bowel problems, a new study says.

People who eat lots after 9 p.m. can be more than twice as likely to experience constipation and diarrhea, researchers will report at the upcoming Digestive Disease Week meeting in Chicago.

“It’s not just what you eat, but when yo...

New Treatment Targets Unaddressed Major Symptom Of Depression Through Joy, Pleasure and Purpose

The most debilitating symptom of depression can be something that’s actually absent — a void representing the inability to feel positive emotions or experience pleasure.

That symptom — known clinically as anhedonia — affects nearly 90% of people with major depression but is left largely unaddressed by conventional t...

Why Pricier Olive Oil May Be Better For Your Brain

When it comes to olive oil, not all are created equal. 

Extra virgin olive oil — the centerpiece of a Mediterranean diet — has benefits for your belly and your brain, new research shows. Refined olive oil, which is generally cheaper to buy, does not.

"Not all olive oils have benefits for cognitive function," said lea...

Your Internal Signal to Stop Eating is More Complex Than Previously Thought

When your belly is full, your brain tells you to "stop eating."

But how that signal works is more complex than scientists have understood — and they hope their discovery that it comes from an unexpected source could lead to new treatments for eating disorders and obesity.

"This research changes how we think about these communic...

Former Tobacco Executive Takes CDC Role

A new hire at the U.S. Centers for Disease Control and Prevention (CDC) is drawing backlash from public health experts who worry about his influence in the industry.

Stephen Sayle, named last month as the CDC’s deputy director for legislative affairs, previously worked for Fontem Ventures, a British tobacco company subsidiary. <...

New Plan Could Speed Medicare Coverage for Innovative Devices

A new proposal could make it easier for patients to access breakthrough medical devices through Medicare.

On Thursday, federal regulators announced a plan they’re calling RAPID. 

The goal? To better coordinate how the U.S. Food and Drug Administration (FDA) and Medicare review these new innovative devices. FDA determines w...